BSE Live
Oct 31, 16:01Prev. Close
381.75
Open Price
388.30
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Oct 31, 15:40Prev. Close
384.30
Open Price
387.35
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
388.35 (30)
| Balance Sheet of Kilitch Drugs (India) (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| EQUITIES AND LIABILITIES | ||||||
| SHAREHOLDER'S FUNDS | ||||||
| Equity Share Capital | 16.08 | 16.08 | 15.58 | 15.58 | 15.49 | |
| Total Share Capital | 16.08 | 16.08 | 15.58 | 15.58 | 15.49 | |
| Reserves and Surplus | 236.86 | 206.49 | 179.99 | 162.09 | 147.09 | |
| Total Reserves and Surplus | 236.86 | 206.49 | 179.99 | 162.09 | 147.09 | |
| Total Shareholders Funds | 252.94 | 222.92 | 195.93 | 178.03 | 162.93 | |
| NON-CURRENT LIABILITIES | ||||||
| Long Term Borrowings | 27.77 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Deferred Tax Liabilities [Net] | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Other Long Term Liabilities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Long Term Provisions | 0.25 | 0.17 | 0.07 | 0.28 | 0.38 | |
| Total Non-Current Liabilities | 28.02 | 0.17 | 0.07 | 0.28 | 0.38 | |
| CURRENT LIABILITIES | ||||||
| Short Term Borrowings | 21.32 | 31.32 | 21.86 | 20.33 | 14.71 | |
| Trade Payables | 47.42 | 26.16 | 28.84 | 27.77 | 13.56 | |
| Other Current Liabilities | 7.01 | 5.59 | 4.21 | 4.87 | 3.46 | |
| Short Term Provisions | 1.44 | 1.31 | 1.51 | 1.01 | 0.81 | |
| Total Current Liabilities | 77.20 | 64.37 | 56.42 | 53.99 | 32.53 | |
| Total Capital And Liabilities | 358.16 | 287.47 | 252.42 | 232.29 | 195.85 | |
| ASSETS | ||||||
| NON-CURRENT ASSETS | ||||||
| Tangible Assets | 19.16 | 15.26 | 14.82 | 13.95 | 6.79 | |
| Intangible Assets | 0.35 | 0.44 | 0.26 | 0.23 | 0.15 | |
| Capital Work-In-Progress | 47.29 | 5.97 | 1.31 | 0.00 | 0.00 | |
| Other Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Fixed Assets | 66.80 | 21.67 | 16.39 | 14.18 | 6.94 | |
| Non-Current Investments | 71.85 | 71.27 | 71.10 | 70.15 | 70.10 | |
| Deferred Tax Assets [Net] | 2.88 | 2.56 | 1.97 | 1.51 | 1.27 | |
| Long Term Loans And Advances | 54.23 | 50.47 | 48.17 | 46.60 | 44.00 | |
| Other Non-Current Assets | 0.02 | 0.01 | 0.02 | 2.14 | 1.76 | |
| Total Non-Current Assets | 195.78 | 145.98 | 137.65 | 134.57 | 124.09 | |
| CURRENT ASSETS | ||||||
| Current Investments | 49.52 | 49.43 | 39.20 | 47.23 | 36.40 | |
| Inventories | 15.31 | 3.99 | 2.04 | 5.00 | 3.59 | |
| Trade Receivables | 83.40 | 61.80 | 53.10 | 41.42 | 22.92 | |
| Cash And Cash Equivalents | 7.46 | 18.63 | 17.97 | 2.45 | 5.77 | |
| Short Term Loans And Advances | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| OtherCurrentAssets | 6.70 | 7.64 | 2.45 | 1.61 | 3.08 | |
| Total Current Assets | 162.38 | 141.49 | 114.77 | 97.72 | 71.76 | |
| Total Assets | 358.16 | 287.47 | 252.42 | 232.29 | 195.85 | |
| OTHER ADDITIONAL INFORMATION | ||||||
| CONTINGENT LIABILITIES, COMMITMENTS | ||||||
| Contingent Liabilities | 0.76 | 0.76 | 0.76 | 0.76 | 0.76 | |
| CIF VALUE OF IMPORTS | ||||||
| Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Stores, Spares And Loose Tools | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Trade/Other Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Capital Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| EXPENDITURE IN FOREIGN EXCHANGE | ||||||
| Expenditure In Foreign Currency | 30.28 | 16.62 | 16.07 | 5.85 | 4.86 | |
| REMITTANCES IN FOREIGN CURRENCIES FOR DIVIDENDS | ||||||
| Dividend Remittance In Foreign Currency | -- | -- | -- | -- | -- | |
| EARNINGS IN FOREIGN EXCHANGE | ||||||
| FOB Value Of Goods | -- | -- | -- | -- | -- | |
| Other Earnings | 103.23 | 77.94 | 60.21 | 50.88 | 18.93 | |
| BONUS DETAILS | ||||||
| Bonus Equity Share Capital | 0.06 | 0.06 | 0.06 | 0.06 | 0.06 | |
| NON-CURRENT INVESTMENTS | ||||||
| Non-Current Investments Quoted Market Value | 0.50 | 0.48 | -- | -- | -- | |
| Non-Current Investments Unquoted Book Value | 71.35 | 70.79 | 71.10 | 69.14 | 70.10 | |
| CURRENT INVESTMENTS | ||||||
| Current Investments Quoted Market Value | -- | -- | 39.20 | -- | 36.40 | |
| Current Investments Unquoted Book Value | 49.52 | 49.43 | -- | 47.23 | -- |
20.05.2025
Kilitch Drugs Consolidated March 2025 Net Sales at Rs 61.23 crore, up 36.61% Y-o-Y
20.05.2025
Kilitch Drugs Standalone March 2025 Net Sales at Rs 56.30 crore, up 43.87% Y-o-Y
28.02.2025
Kilitch Drugs Consolidated December 2024 Net Sales at Rs 56.17 crore, up 76.65% Y-o-Y
17.02.2025
Kilitch Drugs Standalone December 2024 Net Sales at Rs 46.51 crore, up 56.27% Y-o-Y